A start-up co-founded and led by Limerick-born entrepreneur Fares Siddiqui has received fast-track approval in the United States for a remote monitoring system that can help detect Covid-19 symptoms, such as loss of breath. London-based Circadia Health has just received the go-ahead by the US Food and Drug Administration (FDA) for its C100 system, a bedside device which is designed for use in healthcare settings. It uses radar and machine learning to detect changes in a patient’s condition and predict possible respiratory complications, thereby enabling earlier intervention and treatment. “We had just filed for FDA approval when Covid-19 hit in early March,” he said. Circadia got an early boost after it was selected to participate in well-known entrepreneur-turned-investor Sean O’Sullivan’s-backed Hax hardware accelerator programme in China.

Source: The Irish Times July 06, 2020 04:30 UTC